Clinical Pearls in Blood Diseases

You have full text access to this OnlineOpen article

Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura

  1. Robert McMillan1,*,
  2. James B. Bussel2,
  3. James N. George3,
  4. Deepa Lalla4,†,
  5. Janet L. Nichol4

Article first published online: 23 AUG 2007

DOI: 10.1002/ajh.20992

Issue

American Journal of Hematology

American Journal of Hematology

Volume 83, Issue 2, pages 150–154, February 2008

Additional Information

How to Cite

McMillan, R., Bussel, J. B., George, J. N., Lalla, D. and Nichol, J. L. (2008), Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am. J. Hematol., 83: 150–154. doi: 10.1002/ajh.20992

Author Information

  1. 1

    Scripps Research Institute, La Jolla, California

  2. 2

    Weill Cornell Medical Center, New York, New York

  3. 3

    University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

  4. 4

    Amgen Inc., Thousand Oaks, California

  1. †

    Dr. Lalla is no longer employed by Amgen Inc.

*203 12th Street, Del Mar, CA 92014

Publication History

  1. Issue published online: 2 JAN 2008
  2. Article first published online: 23 AUG 2007
  3. Manuscript Accepted: 9 APR 2007
  4. Manuscript Revised: 5 APR 2007
  5. Manuscript Received: 12 JAN 2007

Funded by

  • Amgen Inc.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (154K)

References

  • 1
    Cines DB,Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995–1008.
  • 2
    Cines DB,Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106: 2244–2251.
  • 3
    George JN,El-Harake MA,Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: BeutlerE,LichtmanMA,CollerBS,KippsTJ, editors. Williams Hematology, 5th ed. New York: McGraw-Hill. 1995. pp 1315–1355.
  • 4
    McMillan R,Imbach P. Immune thrombocytopenic purpura. In: LoscalzoJ,SchaferA, editors. Thrombosis and Hemorrhage. Philadelphia: Lippincott Williams & Wilkins; 2003. pp 476–495.
  • 5
    George JN,Woolf SH,Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3–40.
  • 6
    Provan D,Newland A,Bolton-Maggs P. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574–596.
    Direct Link:
  • 7
    Cohen YC,Djulbegovic B,Shamai-Lubovitz O,Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000; 160: 1630–1638.
  • 8
    McMillan R,Durette C. The long-term outcome of adult chronic ITP patients who fail splenectomy. Blood 2004; 104: 956–960.
  • 9
    Barnard D,Woloski M,Feeney D, et al. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol 2003; 25: 56–62.
  • 10
    Streiner DL,Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford: Oxford University Press; 1995.
  • 11
    Ware J. SF-36 Health Survey, manual and interpretation guide. Boston: New England Medical Center, The Health Institute; 1993.
  • 12
    Shrout PE,Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 1979; 2: 420–428.
  • 13
    Cines DB,McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005; 56: 425–442.
  • 14
    Kojouri K,Vesely SK,Terrell DR,George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004; 104: 2623–2634.
  • 15
    Stewart AL,Ware JE. Measuring functioning and well-being: The medical outcomes study approach. Methods of validating health measures. Durham, NC: Duke University Press; 1992.
  • 16
    Ware J. SF-36 Physical and Mental Health Summary Scales: A Manual and Interpretation Guide. Boston: The Health Institute; 1994.
  • 17
    Ware JE,Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I: Conceptual framework and item selection. Med Care 1992; 30: 473–483.
  • 18
    Ware JE,Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 945–952.
  • 19
    Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297–334.
Get PDF (154K)